Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The NIH-wide notice about terminology changes and transition updates was removed from the top of the page.
    Difference
    1%
    Check dated 2026-11-07T13:08:04.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error rather than study details.
    Difference
    0.2%
    Check dated 2026-10-31T13:41:57.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:08:14.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2 while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-17T17:55:15.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1; the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T18:58:40.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown, indicating access to the content is blocked. The page displays the site's header, footer, and navigation as part of the error screen.
    Difference
    18%
    Check dated 2026-09-19T20:25:51.000Z thumbnail image

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.